Skip to main content

Table 2 Laboratory results of the included COVID-19 patients after two sequential negative nucleic acid testing

From: Clinical and CT features of mild-to-moderate COVID-19 cases after two sequential negative nucleic acid testing results: a retrospective analysis

  N Total Moderate Mild P
n Median (IQR) n Median (IQR)
WBC count, × 109 /L 51 5.78 (4.38, 7.70) 31 5.90 (4.84, 8.39) 20 5.62 (3.99, 7.39) 0.298
Neutrophile granulocyte, % 49 55.2 (47.9, 63.3) 30 55.8 (46.9, 63.7) 19 52.4 (41.3, 60) 0.325
Lymphocyte count, ×109 /L 46 2.01 (1.49, 2.53) 28 1.99 (1.41, 2.90) 18 2.07 (1.65, 2.34) 0.839
Lymphocyte, % 51 34.1 (27.9, 41.7) 31 32.3 (23.9, 37.9) 20 35.7 (29.4, 44.6) 0.162
C-reactive protein, mg/L 44 0.73 (0.34, 1.84) 26 0.86 (0.36, 2.04) 18 0.64 (0.21, 1.3) 0.481
D-dimer, μg/mL 20 0.27 (0.22, 0.42) 13 0.25 (0.22, 0.43) 7 0.28 (0.22, 0.39) 0.838
Erythrocyte sedimentation rate, mm/h 10 19 (3.75, 32) 7 19 (4, 24) 3 30 (2, 44) 0.568
Lactate dehydrogenase, U/L 37 362 (323.5, 424) 23 354 (322, 416) 14 369 (322, 448) 0.650
Alanine aminotransferase, U/L 43 21 (16, 36) 27 22 (18, 46) 16 20 (15, 34) 0.606
Aspartate aminotransferase, U/L 43 27 (22, 33) 27 27 (23, 32) 16 26 (20, 33) 0.763